首页 > 最新文献

Practical Diabetes最新文献

英文 中文
Impact of using fasting plasma glucose and HbA1c instead of OGTT as a screening tool for gestational diabetes: a retrospective study 使用空腹血糖和HbA1c代替OGTT作为妊娠期糖尿病筛查工具的影响:一项回顾性研究
IF 0.6 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.1002/pdi.2434
Hannah Cooke, Stephen Craig, H. Kahal, F. Talbot, K. Lonnen
Aims: To examine the impact of using the Royal College of Obstetricians and Gynaecologists (RCOG) COVID‐19 Gestational Diabetes (GDM) criteria on identifying women with GDM.
目的:研究使用皇家妇产科学院(RCOG) COVID - 19妊娠糖尿病(GDM)标准对识别GDM女性的影响。
{"title":"Impact of using fasting plasma glucose and HbA1c instead of OGTT as a screening tool for gestational diabetes: a retrospective study","authors":"Hannah Cooke, Stephen Craig, H. Kahal, F. Talbot, K. Lonnen","doi":"10.1002/pdi.2434","DOIUrl":"https://doi.org/10.1002/pdi.2434","url":null,"abstract":"Aims: To examine the impact of using the Royal College of Obstetricians and Gynaecologists (RCOG) COVID‐19 Gestational Diabetes (GDM) criteria on identifying women with GDM.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84869457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic kidney disease awareness and updates on the management of diabetic kidney disease 慢性肾脏疾病的认识和糖尿病肾病管理的最新进展
IF 0.6 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.1002/pdi.2454
Wigdan Hamza, J. Burton
The prevalence of chronic kidney disease (CKD) is rising worldwide and is a major contributor to morbidity and mortality. It is estimated to affect over 800 million people globally.
慢性肾脏疾病(CKD)的患病率正在全球范围内上升,并且是发病率和死亡率的主要因素。据估计,全球有8亿多人受到影响。
{"title":"Chronic kidney disease awareness and updates on the management of diabetic kidney disease","authors":"Wigdan Hamza, J. Burton","doi":"10.1002/pdi.2454","DOIUrl":"https://doi.org/10.1002/pdi.2454","url":null,"abstract":"The prevalence of chronic kidney disease (CKD) is rising worldwide and is a major contributor to morbidity and mortality. It is estimated to affect over 800 million people globally.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87514084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual infections and diabetes: dangerous fungi 异常感染和糖尿病:危险的真菌
IF 0.6 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.1002/pdi.2440
R. Hillson
World Health Organisation In October 2022, WHO issued a warning: ‘Fungal pathogens are a major threat to public health as they are becoming increasingly common and resistant to treatment...Most fungal pathogens lack rapid and sensitive diagnostics...During the COVID-19 pandemic, the reported incidence of invasive fungal infections increased significantly among hospitalized patients... Despite the growing concern, fungal infections receive very little attention and resources.’2
2022年10月,世卫组织发出警告:“真菌病原体正变得越来越普遍,并且对治疗具有抗药性,因此对公众健康构成了重大威胁……大多数真菌病原体缺乏快速和敏感的诊断……在2019冠状病毒病大流行期间,住院患者中侵袭性真菌感染的发病率显著增加……尽管人们越来越关注真菌感染,但真菌感染得到的关注和资源却很少
{"title":"Unusual infections and diabetes: dangerous fungi","authors":"R. Hillson","doi":"10.1002/pdi.2440","DOIUrl":"https://doi.org/10.1002/pdi.2440","url":null,"abstract":"World Health Organisation In October 2022, WHO issued a warning: ‘Fungal pathogens are a major threat to public health as they are becoming increasingly common and resistant to treatment...Most fungal pathogens lack rapid and sensitive diagnostics...During the COVID-19 pandemic, the reported incidence of invasive fungal infections increased significantly among hospitalized patients... Despite the growing concern, fungal infections receive very little attention and resources.’2","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88519411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Combined COVID‐19 and influenza infection: an imminent ‘double whammy’ ahead? COVID - 19和流感合并感染:迫在眉睫的“双重打击”?
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2421
K. Shaw
A the winter of 2022–23 approaches, concern is already developing about the prospect of a dual co-infection with simultaneous SARS-CoV-2 (COVID-19/ Omicron) and influenza A (currently H3N2). Furthermore, as a result of essential measures put in place over the last couple of years to mitigate risk of transmitting COVID infection, the incidence of seasonal influenza has been substantially less than in previous years, raising the potential probability of a more susceptible population with a lessened natural immunity to influenza infection. Indeed, present reports from Australia, inevitably the prelude to later western experience, indicate a rapid rise in influenza A notifications, a challenge reinforced by declining uptake of seasonal influenza vaccine both in Australia and the UK.1
随着2022-23年冬季的临近,人们已经开始担心SARS-CoV-2 (COVID-19/ Omicron)和甲型流感(目前为H3N2)双重合并感染的前景。此外,由于过去几年为降低传播COVID感染的风险而采取的基本措施,季节性流感的发病率已大大低于往年,从而增加了对流感感染的天然免疫力降低的易感人群的潜在可能性。事实上,目前来自澳大利亚的报告,不可避免地是后来西方经验的前奏,表明甲型流感报告迅速增加,澳大利亚和英国季节性流感疫苗的接种率下降加强了这一挑战
{"title":"Combined COVID‐19 and influenza infection: an imminent ‘double whammy’ ahead?","authors":"K. Shaw","doi":"10.1002/pdi.2421","DOIUrl":"https://doi.org/10.1002/pdi.2421","url":null,"abstract":"A the winter of 2022–23 approaches, concern is already developing about the prospect of a dual co-infection with simultaneous SARS-CoV-2 (COVID-19/ Omicron) and influenza A (currently H3N2). Furthermore, as a result of essential measures put in place over the last couple of years to mitigate risk of transmitting COVID infection, the incidence of seasonal influenza has been substantially less than in previous years, raising the potential probability of a more susceptible population with a lessened natural immunity to influenza infection. Indeed, present reports from Australia, inevitably the prelude to later western experience, indicate a rapid rise in influenza A notifications, a challenge reinforced by declining uptake of seasonal influenza vaccine both in Australia and the UK.1","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80846732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediabetes screening, treatment, and follow‐up in primary health care: a cross‐sectional survey 初级卫生保健中的糖尿病前期筛查、治疗和随访:一项横断面调查
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2425
Katri Harcke, M. Graue, T. Skinner, Christina B Olsson, Nouha Saleh Stattin
Aim: This study aimed to describe routines for screening, treatment, and follow‐up for prediabetes at primary health care centres in Region Stockholm, Sweden.
目的:本研究旨在描述瑞典斯德哥尔摩地区初级卫生保健中心对前驱糖尿病的常规筛查、治疗和随访。
{"title":"Prediabetes screening, treatment, and follow‐up in primary health care: a cross‐sectional survey","authors":"Katri Harcke, M. Graue, T. Skinner, Christina B Olsson, Nouha Saleh Stattin","doi":"10.1002/pdi.2425","DOIUrl":"https://doi.org/10.1002/pdi.2425","url":null,"abstract":"Aim: This study aimed to describe routines for screening, treatment, and follow‐up for prediabetes at primary health care centres in Region Stockholm, Sweden.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78955860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common tests for diabetic peripheral neuropathy 糖尿病周围神经病变的常用检查
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2428
K. Bishop, R. Poole
In this fifth article in our ‘Test Tips’ series, Dr Katherine Bishop and Dr Ruth Poole examine the relative benefits and limitations of the four commonly‐used tests for diabetic peripheral neuropathy.
在我们“测试提示”系列的第五篇文章中,Katherine Bishop博士和Ruth Poole博士研究了糖尿病周围神经病变的四种常用测试的相对益处和局限性。
{"title":"Common tests for diabetic peripheral neuropathy","authors":"K. Bishop, R. Poole","doi":"10.1002/pdi.2428","DOIUrl":"https://doi.org/10.1002/pdi.2428","url":null,"abstract":"In this fifth article in our ‘Test Tips’ series, Dr Katherine Bishop and Dr Ruth Poole examine the relative benefits and limitations of the four commonly‐used tests for diabetic peripheral neuropathy.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91284375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supporting people with type 2 diabetes who need insulin 支持需要胰岛素的2型糖尿病患者
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2424
K. Winkley
The year 2022 marks 100 years since the first person with diabetes received an insulin injection and supporting people with insulin self‐management is a core role for diabetes nurses. Janet Kinson was a diabetes nurse and author. She developed the first diabetes education programme for nurses and the topic of insulin was central to the curriculum. This article will honour the contribution she made by focusing on diabetes education for people with type 2 diabetes who need insulin. It will start by tracing why and when people with type 2 diabetes should start insulin treatment followed by an exploration of the barriers to starting insulin at the level of the individual, the health care professional and the health system. We know that around 50% of people with type 2 diabetes delay starting insulin for seven years when it is clinically indicated. We also know that around a third of people with type 2 diabetes who are insulin treated remain hyperglycaemic or experience frequent hypoglycaemia. Therefore, there is a need for interventions that address delay, optimise starting insulin as well as consider how we best support people with type 2 diabetes to persist with and intensify their insulin over the diabetes journey. This article presents the current literature on interventions to support people with type 2 diabetes with insulin and identify gaps in support that may be addressed in future research. Copyright © 2022 John Wiley & Sons..
2022年是第一位糖尿病患者接受胰岛素注射100周年,支持患者进行胰岛素自我管理是糖尿病护士的核心职责。珍妮特·金森是一名糖尿病护士和作家。她为护士制定了第一个糖尿病教育计划,胰岛素的主题是课程的核心。这篇文章将表彰她对需要胰岛素的2型糖尿病患者的糖尿病教育做出的贡献。它将首先追踪2型糖尿病患者为什么以及何时应该开始胰岛素治疗,然后探索在个人、卫生保健专业人员和卫生系统层面开始胰岛素治疗的障碍。我们知道,约有50%的2型糖尿病患者在临床需要时延迟7年才开始使用胰岛素。我们还知道,大约三分之一接受胰岛素治疗的2型糖尿病患者仍然患有高血糖或经常出现低血糖。因此,有必要采取干预措施,解决延迟问题,优化胰岛素启动,并考虑如何最好地支持2型糖尿病患者在糖尿病过程中坚持并加强胰岛素治疗。这篇文章介绍了目前关于支持2型糖尿病患者使用胰岛素的干预措施的文献,并确定了在未来研究中可能解决的支持差距。版权所有©2022 John Wiley & Sons。
{"title":"Supporting people with type 2 diabetes who need insulin","authors":"K. Winkley","doi":"10.1002/pdi.2424","DOIUrl":"https://doi.org/10.1002/pdi.2424","url":null,"abstract":"The year 2022 marks 100 years since the first person with diabetes received an insulin injection and supporting people with insulin self‐management is a core role for diabetes nurses. Janet Kinson was a diabetes nurse and author. She developed the first diabetes education programme for nurses and the topic of insulin was central to the curriculum. This article will honour the contribution she made by focusing on diabetes education for people with type 2 diabetes who need insulin. It will start by tracing why and when people with type 2 diabetes should start insulin treatment followed by an exploration of the barriers to starting insulin at the level of the individual, the health care professional and the health system. We know that around 50% of people with type 2 diabetes delay starting insulin for seven years when it is clinically indicated. We also know that around a third of people with type 2 diabetes who are insulin treated remain hyperglycaemic or experience frequent hypoglycaemia. Therefore, there is a need for interventions that address delay, optimise starting insulin as well as consider how we best support people with type 2 diabetes to persist with and intensify their insulin over the diabetes journey. This article presents the current literature on interventions to support people with type 2 diabetes with insulin and identify gaps in support that may be addressed in future research. Copyright © 2022 John Wiley & Sons..","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73302866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical/biochemical characteristics and related outcomes in people with new‐onset diabetes and COVID‐19: experience from a single centre 新发糖尿病和COVID - 19患者的临床/生化特征和相关结果:来自单一中心的经验
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2426
Diego Mun oz Moreno, R. J. Ramos, Laura González Fernández, Alejandra Maricel Rivas Montenegro, María Miguélez González, Noemí Brox Torrecilla, O. G. Albarrán
Aims: It is known that there is a bidirectional relationship between diabetes mellitus (DM) and coronavirus disease (COVID‐19). It has been described that those patients infected with SARS‐CoV‐2 could develop severe metabolic decompensation of pre‐existing or new‐onset DM, although diabetogenic effect of SARS‐CoV‐2 has still not been well consolidated. In fact, the coexistence of SARS‐CoV‐2 infection and new‐onset DM is an infrequent situation.
目的:糖尿病(DM)与冠状病毒病(COVID - 19)之间存在双向关系。尽管SARS - CoV - 2的致糖尿病作用尚未得到很好的证实,但已有研究表明,感染SARS - CoV - 2的患者可能会出现严重的糖尿病代谢性失代偿。事实上,SARS - CoV - 2感染与新发糖尿病共存是一种罕见的情况。
{"title":"Clinical/biochemical characteristics and related outcomes in people with new‐onset diabetes and COVID‐19: experience from a single centre","authors":"Diego Mun oz Moreno, R. J. Ramos, Laura González Fernández, Alejandra Maricel Rivas Montenegro, María Miguélez González, Noemí Brox Torrecilla, O. G. Albarrán","doi":"10.1002/pdi.2426","DOIUrl":"https://doi.org/10.1002/pdi.2426","url":null,"abstract":"Aims: It is known that there is a bidirectional relationship between diabetes mellitus (DM) and coronavirus disease (COVID‐19). It has been described that those patients infected with SARS‐CoV‐2 could develop severe metabolic decompensation of pre‐existing or new‐onset DM, although diabetogenic effect of SARS‐CoV‐2 has still not been well consolidated. In fact, the coexistence of SARS‐CoV‐2 infection and new‐onset DM is an infrequent situation.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81174409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Dapagliflozin and euglycaemic diabetic ketoacidosis – ‘But doctor my sugars were normal!’ 达格列净和糖尿病酮症酸中毒——但是医生,我的血糖是正常的!”
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2430
K. Watters, V. Greener, Akaterini Theodoraki, E. Nogueira, K. Shotliff
{"title":"Dapagliflozin and euglycaemic diabetic ketoacidosis – ‘But doctor my sugars were normal!’","authors":"K. Watters, V. Greener, Akaterini Theodoraki, E. Nogueira, K. Shotliff","doi":"10.1002/pdi.2430","DOIUrl":"https://doi.org/10.1002/pdi.2430","url":null,"abstract":"","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85899390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Window of opportunity: screening for GCK monogenic diabetes in the antenatal diabetes clinic 机会之窗:筛查GCK单基因糖尿病在产前糖尿病诊所
IF 0.6 Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1002/pdi.2427
Aarthi Surendran, A. Brackenridge, S. White
Monogenic diabetes (MODY) is a rare, inherited form of diabetes, of which glucokinase (GCK) mutation is one of the most common forms. Correct diagnosis is important, particularly during pregnancy, as treatment should be tailored accordingly. In our antenatal diabetes clinic, we audited those eligible for genetic screening over a one‐year period as per European Best Practice guidelines (2008) and new NHS England criteria (2021), as well as those identified with the mutation. Our audit recorded a significant drop in the number of eligible women identified using new criteria (2.6% vs 5.2%), with a notable reduction in women of African ethnicity (15.2% vs 29.2%). The audit highlighted the need for increased health care professional awareness and the implementation of clear pathways within the antenatal diabetes service to facilitate identification of women for genetic screening and subsequent appropriate management. It also underlined the importance of ongoing assessment of the clinical performance of the new screening criteria. Copyright © 2022 John Wiley & Sons.
单基因糖尿病(MODY)是一种罕见的遗传性糖尿病,其中葡萄糖激酶(GCK)突变是最常见的形式之一。正确的诊断很重要,特别是在怀孕期间,因为治疗应该相应地量身定制。在我们的产前糖尿病诊所,我们根据欧洲最佳实践指南(2008年)和新的NHS英格兰标准(2021年)审核了那些符合一年遗传筛查条件的患者,以及那些确定有突变的患者。我们的审计记录显示,使用新标准确定的符合条件的妇女人数显著下降(2.6%对5.2%),非洲裔妇女人数显著减少(15.2%对29.2%)。审计突出指出,需要提高保健专业人员的认识,并在产前糖尿病服务部门内实施明确的途径,以便利查明妇女进行遗传筛查和随后的适当管理。它还强调了对新筛查标准的临床表现进行持续评估的重要性。版权所有©2022 John Wiley & Sons。
{"title":"Window of opportunity: screening for GCK monogenic diabetes in the antenatal diabetes clinic","authors":"Aarthi Surendran, A. Brackenridge, S. White","doi":"10.1002/pdi.2427","DOIUrl":"https://doi.org/10.1002/pdi.2427","url":null,"abstract":"Monogenic diabetes (MODY) is a rare, inherited form of diabetes, of which glucokinase (GCK) mutation is one of the most common forms. Correct diagnosis is important, particularly during pregnancy, as treatment should be tailored accordingly. In our antenatal diabetes clinic, we audited those eligible for genetic screening over a one‐year period as per European Best Practice guidelines (2008) and new NHS England criteria (2021), as well as those identified with the mutation. Our audit recorded a significant drop in the number of eligible women identified using new criteria (2.6% vs 5.2%), with a notable reduction in women of African ethnicity (15.2% vs 29.2%). The audit highlighted the need for increased health care professional awareness and the implementation of clear pathways within the antenatal diabetes service to facilitate identification of women for genetic screening and subsequent appropriate management. It also underlined the importance of ongoing assessment of the clinical performance of the new screening criteria. Copyright © 2022 John Wiley & Sons.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72473504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Practical Diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1